I’m surprised that someone felt it necessary to conduct a formal study of this. A glance at multiple sclerosis (MS) groups on social media, although unscientific, would suggest that this is a common problem. And if you’re going to do a study, why limit it to women? A lot of guys with MS have problems in this area, too.
The high prevalence of sexual problems among these women may be linked to their age, degree of physical disability, and depression, according to researchers.
Click here to read the entire story.
Relapsing MS Patients Highly Satisfied with Aubagio’s Efficacy and Ease of Use, Global Clinical Study Finds
The results of this study don’t surprise me. I was treated with Aubagio (teriflunomide) and was very satisfied with it. Take note, however, that each of the study’s 10 authors is either an employee of Sanofi Genzyme, the company that makes Aubagio, or has received consulting fees from it.
High levels of satisfaction with the efficacy and convenience of Aubagio (teriflunomide), an oral treatment for relapsing multiple sclerosis, were reported by patients across the U.S. and 13 other countries, a post-hoc analysis of data from a real-world Phase 4 study found.
The study, “Teriflunomide real-world evidence: Global differences in the phase 4 Teri-PRO study,” was published in the journal Multiple Sclerosis and Related Disorders.
Click here to read the full story.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?